Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.

Source:http://linkedlifedata.com/resource/pubmed/id/18375820

Download in:

View as

General Info

PMID
18375820